Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
Collyns, Olivia J., Meier, Renee A., Betts, Zara L., Chan, Denis S.H., Frampton, Chris, Frewen, Carla M., Hewapathirana, Niranjala M., Jones, Shirley D., Roy, Anirban, Grosman, Benyamin, Kurtz, Natalie, Shin, John, Vigersky, Robert A., Wheeler, Benjamin J., de Bock, Martin I.·2021·Diabetes Care
Cited by (276)
Items 101–200 of 276
- Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical TrialsClaudio Cobelli, Chiara Dalla Man · 2021 · Journal of Diabetes Science and Technology
- Candidate Selection for Hybrid Closed Loop SystemsGregory P. Forlenza, Marc D. Breton, Boris P. Kovatchev · 2021 · Diabetes Technology & Therapeutics
- Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort StudyChristian Laugesen, Tobias Ritschel, Ajenthen Gayathri Ranjan, Liana J. Hsu, John Bagterp Jørgensen, Jannet Svensson, Laya Ekhlaspour, Bruce A. Buckingham, Kirsten Nørgaard · 2024 · Diabetes Technology & Therapeutics
- Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptomsLía Nattero‐Chávez, Edurne Lecumberri Pascual, Esther de la Calle de la Villa, Ane Bayona Cebada, Teresa Ruiz, Alejandra Quintero Tobar, Mar Lorenzo, Cristina Sánchez, Ana Izquierdo, Manuel Luque‐Ramírez et al. · 2023 · Diabetes Research and Clinical Practice
- Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?Valentina Maria Cambuli, Marco Giorgio Baroni · 2023 · International Journal of Molecular Sciences
- Clinical Outcomes with MiniMed TM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 DiabetesMary Binsu Abraham, Grant J. Smith, Julie Dart, Elizabeth Ann Davis, Timothy William Jones · 2024 · Diabetes Technology & Therapeutics
- Unmet needs in the treatment of type 1 diabetes: why is it so difficult to achieve an improvement in metabolic control?Francesco Antonio Mazzotta, Lorenzo Lucaccini Paoli, Alessandro Rizzi, Linda Tartaglione, Maria Laura Leo, Valentina Popolla, Annarita Barberio, Luca Viti, Mauro A. S. Di Leo, Alfredo Pontecorvi et al. · 2024 · Nutrition and Diabetes
- The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G systemJavier Castañeda, Arcelia Arrieta, Tim R. A. van den Heuvel, Ohad Cohen · 2023 · Diabetes Obesity and Metabolism
- Evidence from clinical trials on high-risk medical devices in children: a scoping reviewKathrin Guerlich, Bernadeta Patro-Gołąb, Paulina Dworakowski, Alan G. Fraser, Michael Kammermeier, Tom Melvin, Berthold Viktor Koletzko · 2023 · Pediatric Research
- Closed-Loop Artificial Pancreas Therapy for Type 1 DiabetesKeren Zhou, Diana M. Isaacs · 2022 · Current Cardiology Reports
- Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trialsSergio Di Molfetta, Ludovico Di Gioia, Irene Caruso, Mariangela Caporusso, Paolo Trerotoli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino · 2025 · Diabetes Obesity and Metabolism
- MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life ExperienceMarianna Rachmiel, Yael Lebenthal, Kineret Mazor‐Aronovitch, Avivit Brener, Noah Levek, Talia Jacobi‐Polishook, Tal Ben Ari, Shirli Abiri, Zohar Landau, Orit Pinhas‐Hamiel · 2023 · Diabetes Technology & Therapeutics
- Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetesNicola Shannon, Javier Castañeda, Pratik Choudhary, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Charles H. Thivolet, Mark L. Evans, Roseline Ré, Jessica Cellot et al. · 2023 · Diabetes Obesity and Metabolism
- Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility CriteriaRodolfo Javier Galindo, Grazia Aleppo, Christopher G. Parkin, David A. Baidal, Anders L. Carlson, Eda Cengiz, Gregory P. Forlenza, Davida F. Kruger, Carol Joan Levy, Janet B. McGill et al. · 2022 · Journal of Diabetes Science and Technology
- Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative ReviewPeter Adolfsson, Ragnar Hanås, Dessi P. Zaharieva, Klemen Dovč, JOHAN H. JENDLE · 2024 · Journal of Diabetes Science and Technology
- Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop SystemJothydev Kesavadev, Anjana Basanth, Gopika Krishnan, Arun Shankar, Geethu Sanal, Sunitha Jothydev · 2023 · Diabetes Therapy
- Switching from treatment with sensor augmented pump to hybrid closed loop system in type 1 diabetes: impact on glycemic control and neuropsychological tests in the real worldAmigó, Judit, Ortiz-Zúñiga, Ángel, de Urbina, Ana M. Ortiz, Sánchez, Mònica, Dos-Santos, Marcos, Abad, Mercè, Cuadra, Fátima, Simó, Rafael, Hernández, Cristina, Simó-Servat, Olga · 2023 · Diabetes Research and Clinical Practice
- The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System Compared to Standard Management of Type 1 Diabetes in a Singapore SettingDaphne Su-Lyn Gardner, Mrinmayee Lakkad, Zhiyu Qiu, Yuta Inoue, SURESH RAMA CHANDRAN, Kael Wherry · 2024 · Diabetes Technology & Therapeutics
- Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog®Benyamin Grosman, Di Wu, Neha Parikh, Anirban Roy, Gayane R. Voskanyan, Natalie Kurtz, Jeppe Sturis, Ohad Cohen, Magnus Ekelund, Robert Alan Vigersky · 2021 · Computer Methods and Programs in Biomedicine
- Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic reviewChiara Mameli, Giulia Marie Smylie, Alessio Galati, Biagio Rapone, Roque Cardona‐Hernandez, Gianvincenzo Zuccotti, Maurizio Delvecchio · 2023 · European Journal of Pediatrics
- Glucose control during Ramadan in a pediatric cohort with type 1 diabetes on MiniMed standard and advanced hybrid closed‑loop systems: A pilot studySelmen Wannes, Gehad Mohamed Gamal, Manel Ben Fredj, Dhai Al Qusayer, Sameh El Abed, Yasser Sedky, Munther Khalil · 2023 · Diabetes Research and Clinical Practice
- Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose MonitoringNoelia Gros Herguido, Sandra Amuedo, Virginia Bellido, Gema López Gallardo, Fernando Losada, Ana Pérez-Morales, Carmen Amelia Ruiz Trillo, Alfonso Soto Moreno · 2022 · Diabetes Technology & Therapeutics
- MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert RecommendationsNancy Samir Elbarbary, Abdullah M. Alguwaihes, HAWAZEN A. ZARIF, Mohammed Hassanein, Asma Deeb, Goran Petrovski, Raed Aldahash, Reem Al Amoudi, Sufyan Hussain, Mahmoud Ashraf Ibrahim et al. · 2024 · Diabetes Technology & Therapeutics
- Advanced hybrid closed-loop system: first successful clinical case after total pancreatectomyAlessandro Rizzi, Linda Tartaglione, Mauro A. S. Di Leo, Sergio Alfieri, Dario Pitocco · 2021 · Acta Diabetologica
- Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in childrenLucia Ferrito, Stefano Passanisi, Riccardo Bonfanti, Valentino Cherubini, Nicola Minuto, Riccardo Schiaffini, Andrea Enzo Scaramuzza · 2021 · Minerva Pediatrics
- Diabetes Management in Transition: Market Insights and Technological Advancements in CGM and Insulin DeliveryTae Sang Yu, Soojeong Song, Junwoo Yea, Kyung‐In Jang · 2024 · Advanced Sensor Research
- Use of intermittently scanned continuous glucose monitoring in young people with high‐risk type 1 diabetes—Extension phase outcomes following a 6‐month randomized control trialShelley Rose, Sara E. Styles, Esko J. Wiltshire, James Stanley, Barbara C. Galland, Martin I. de Bock, Paul A. Tomlinson, Jenny A. Rayns, Karen E. MacKenzie, Benjamin John Wheeler · 2021 · Diabetic Medicine
- Commercial Aspects and Market Pull of Biosensors in Diagnostic IndustriesAshutosh Kumar, Kuldeep Mahato, Buddhadev Purohit, Pranjal Chandra · 2022 · Springer eBooks
- In Silico Evaluation of the Medtronic 780G System While Using the GS3 and Its Calibration-Free Successor, the G4S SensorBenyamin Grosman, Neha Parikh, Anirban Roy, LOUIS J. LINTEREUR, Robert Alan Vigersky, Ohad Cohen, Andrew S. Rhinehart · 2022 · Annals of Biomedical Engineering
- Efficacy of automated insulin delivery in pregnant women with type 1 diabetes: a meta-analysis and trial sequential analysis of randomized controlled trialsTamara Teixeira, Amanda Godoi, Pedro Henrique Carvalho Leite Romeiro, João Vitor Levindo Coelho Novaes, Flavia Maria de Freitas Faria, Sacha Fernandes Pereira, Rodrigo Nunes Lamounier · 2024 · Acta Diabetologica
- Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G systemYongwen Zhou, Alisa Boucsein, Venus R. Michaels, Madeleine K. Gray, Craig Jefferies, Esko J. Wiltshire, Ryan G. Paul, Amber Parry‐Strong, Maheen Pasha, Goran Petrovski et al. · 2025 · Diabetes Obesity and Metabolism
- Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin DeliveryMatilda M.E. Johansson, Francesc March de Ribot, Mary-Jane Sime, Alisa Boucsein, Yongwen Zhou, Craig Jefferies, Ryan G. Paul, Esko J. Wiltshire, Mary Binsu Abraham, Timothy W. Jones et al. · 2025 · Diabetes Technology & Therapeutics
- Effects of hybrid closed‐loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor‐augmented pump: A prospective single‐center observational studyTomoaki Akiyama, Tadashi Yamakawa, Kazuki Orime, Masahiro Ichikawa, Marina Harada, Takumi Netsu, Ryoichi Akamatsu, Keita Nakamura, Satoru Shinoda, Yasuo Terauchi · 2023 · Journal of Diabetes Investigation
- Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trialTom Wilkinson, Dunya Tomic, Erin Boyle, David Burren, Yasser Elghattis, Alicia Josephine Jenkins, Celeste Keesing, Sonia Middleton, Natalie Nanayakkara, Jonathan A. Williman et al. · 2024 · BMJ Open
- Protocol for a prospective, multicenter, parallel-group, open-label randomized controlled trial comparing standard care with Closed lOoP In chiLdren and yOuth with Type 1 diabetes and high-risk glycemic control: the CO-PILOT trialAlisa Boucsein, Yongwen Zhou, Jillian Joy Haszard, Craig Jefferies, Esko J. Wiltshire, Sara E. Styles, Hamish R. Crocket, Barbara C. Galland, Maheen Pasha, Goran Petrovski et al. · 2024 · Journal of Diabetes & Metabolic Disorders
- The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetesArzu Jalilova, Birsen Şentürk Pilan, Günay Demir, Burcu Özbaran, Hanife Gül Balkı, Emrullah Arslan, Sezen Köse, Samim Özen, Şükran Darcan, Damla Gökşen · 2024 · European Journal of Pediatrics
- Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoringCharles H. Thivolet, Mélanie Gaudillière, Sylvie Fimbel, Nathalie Bendelac, B. Mestre, N. Protsenko, S. Brunot, Marc P Nicolino · 2021 · Acta Diabetologica
- Comparison of the Sensor-Augmented Pump System with the Advanced Hybrid Closed-Loop Delivery System: Quality of Life, Diabetes Distress, and Glycaemic Outcomes in a Real-Life ContextEmmanouil S. Benioudakis, Eleni Karlafti, Argyroula E. Kalaitzaki, Maria-Alexandra Kalpou, Evangelos D. Georgiou, Christos G. Savopoulos, Triantafyllos Didangelos · 2023 · Current Diabetes Reviews
- User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitative studyShekhar Sehgal, Martin I. de Bock, Shirley Jones, Carla M. Frewen, Benjamin John Wheeler · 2023 · Frontiers in Endocrinology
- The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference 22‐25 February 2023 I Berlin & OnlineAfroditi Tripyla, A. Ferreira, K. Schoenenberger, Noah H. Näf, Lukas E. Inderbitzin, Luca Cossu, Giacomo Cappon, Andrea Facchinetti, D. Herzig, Lia Bally · 2023 · Diabetes Technology & Therapeutics
- Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based TherapiesYining Xu, Daniel J. Drucker, Giovanni Traverso, Ana Beloqui · 2025 · Endocrine Reviews
- Can the AHCL System Be Used in T1D Patients with Borderline TDDI? A Case ReportAnna Tekielak, Sebastian Seget, Ewa Rusak, Przemysława A. Jarosz-Chobot · 2021 · Sensors
- Real-World Performance of First- Versus Second-Generation Automated Insulin Delivery Systems on a Pediatric Population With Type 1 Diabetes: A One-Year Observational StudyBruno Bombaci, Stefano Passanisi, Mariella Valenzise, Fabio Macrì, Marco Calderone, Senad Hasaj, Sofia Zullo, Giuseppina Salzano, Fortunato Lombardo · 2023 · Journal of Diabetes Science and Technology
- Efficacy of the hybrid closed-loop insulin delivery system in children and adolescents with type 1 diabetes: a meta-analysis with trial sequential analysisRafael Oliva Morgado Ferreira, Talita Trevisan, Eric Pasqualotto, Pedro Schmidt, Matheus Pedrotti, Janine Midori Figueiredo Watanabe, Simone van de Sande‐Lee · 2024 · Archives of Endocrinology and Metabolism
- Long‐term health economic evaluation of automated insulin delivery system compared with continuous subcutaneous insulin infusion pumps and CGM in a real‐world setting in Finnish paediatric and adult individuals with type 1 diabetesHeta‐Leena Vallivaara, Hanna A. Leppänen, Jyrki Mustonen, Antti Saari, Janne A. Martikainen, Reeta M. Rintamäki · 2025 · Diabetes Obesity and Metabolism
- Securing automated insulin delivery systems: A review of security threats and protective strategiesYuchen Niu, Siew-Kei Lam · 2025 · Computers & Security
- Automated Insulin Delivery in Adults With Type 1 Diabetes and Suboptimal HbA1c During Prior Use of Insulin Pump and Continuous Glucose Monitoring: A Randomized Controlled TrialMerete Bechmann Christensen, Ajenthen Gayathri Ranjan, Karen Rytter, Olivia M. McCarthy, Signe Schmidt, Kirsten Nørgaard · 2024 · Journal of Diabetes Science and Technology
- Closed-loop therapy: recent advancements and potential predictors of glycemic outcomesChloë Royston, Roman Hovorka, Charlotte K. Boughton · 2025 · Expert Opinion on Drug Delivery
- The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatmentCarmen Quirós, Núria Alonso-Carril, Silvia Rodriguez-Rodríguez, María José Barahona, Aida Orois, Andreu Simó-Servat, Montserrat Ramos, Verónica Perea · 2022 · Endocrinología Diabetes y Nutrición
- The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatmentCarmen Quirós, Núria Alonso-Carril, Silvia Rodriguez-Rodríguez, María José Barahona, Aida Orois, Andreu Simó-Servat, Montserrat Ramos, Verónica Perea · 2023 · Endocrinología Diabetes y Nutrición (English ed )
- Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop systemAntonio Rossi, Laura Bacchelli Montefusco, Elia Reseghetti, Ida Pastore, Giada Rossi, Vera Usuelli, Cristian Loretelli, Denisa Boci, Moufida Ben Nasr, Francesca D’Addio et al. · 2023 · Diabetes Research and Clinical Practice
- Consensus statement on novel glucose-related metrics obtained through advanced medical devices: English versionRimei Nishimura, Yosuke Okada, Akio Kuroda, Junichi Suzuki, Yushi Hirota, Munehide Matsuhisa, Mizuki Ishiguro, Takayuki Ohno, Yuka Suganuma, Kenichi Tanaka et al. · 2025 · Diabetology International
- Insurance Coverage for Emerging Diabetes Technologies: Payers' PerspectiveTim Nolan, Marie A. Frazzitta · 2021 · Diabetes Technology & Therapeutics
- Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children’s Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery SystemsThomas Simon James Crabtree, Pratik Choudhary, Alistair N. Lumb, Peter J. Hammond, Alasdair McLay, Fiona Campbell, Sze May Ng, Emma G. Wilmot, Sufyan Hussain · 2022 · Diabetes Therapy
- Associations between clinical and psychosocial factors and HbA1c in adult insulin pump users with type 1 diabetesS. Schmidt, K. P. Madsen, U. Pedersen-Bjergaard, Karen Rytter, E. Hommel, B. Cleal, I. Willaing, H. U. Andersen, K. Nørgaard · 2023 · Acta Diabetologica
- Efficacy and safety of closed-loop control system for type one diabetes in adolescents a meta analysisMosleh Ali Jabari · 2023 · Scientific Reports
- Actualisation de la prise de position des experts français sur l’insulinothérapie automatisée en boucle ferméeÉric Renard, Nadia Tubiana‐Rufi, Lucy Chaillous, Élisabeth Bonnemaison, Hélène P. Hanaire, Élise Bismuth, Michaël Joubert, R. Coutant, Pauline Schaepelynck, Jacques Beltrand et al. · 2024 · Médecine des Maladies Métaboliques
- Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective TrialNoah Gruber, Avigail Wittenberg, Avivit Brener, Shirli Abiri, Kineret Mazor‐Aronovitch, Michal Yackobovitch‐Gavan, Shay Averbuch, Tal Ben Ari, Noah Levek, Neriya Levran et al. · 2024 · Diabetes Technology & Therapeutics
- Microvascular disease and early diabetes onset are associated with deficits in femoral neck bone density and structure among older adults with longstanding type 1 diabetesFjóla Jóhannesdóttir, Trinity Tedtsen, Laura M. Cooke, Sarah Mahar, Meng Zhang, Jordan Nustad, Margaret Garrahan, Sarah Gehman, Elaine Wei-Yin Yu, Mary Bouxsein · 2024 · Journal of Bone and Mineral Research
- Automated Insulin Delivery Systems: Today, Tomorrow and User RequirementsMarga Giménez, Ignacio Conget, Nick S. Oliver · 2021 · Journal of Diabetes Science and Technology
- A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory StudyMartina Parise, Sergio Di Molfetta, Roberta Teresa Graziano, Raffaella Fiorentino, Antonio Cutruzzolà, Agostino Gnasso, Concetta Irace · 2023 · International Journal of Environmental Research and Public Health
- Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: A Narrative Review of Challenges and Proposed SolutionsMichael Schoemaker, Anna Martensson, Julia Katharina Mader, Kirsten Nørgaard, Guido Freckmann, Pierre‐Yves Benhamou, Peter Diem, Lutz Heinemann · 2023 · Journal of Diabetes Science and Technology
- Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetesMarta Bassi, Giordano Spacco, Federico Pezzotta, Margherita Di Jorgi, Giulia Siri, Andrea Pintabona, Maria Grazia Calevo, Nicola Minuto, Mohamad Maghnie · 2025 · Frontiers in Endocrinology
- Real‐world glycaemic outcomes observed with the use of Medtronic 780G , Tandem Control‐ IQ and Omnipod 5 automated insulin delivery systemsMuhammad S. Khan, Sathana Sivanantham, Lavanta Farouk, Deeksha Reddy Lakshmareddy, Sara De Scolasticis, Elisabeth Cresta, Ian F. Godsland, Parizad Avari, Nick S. Oliver, Lalantha Leelarathna et al. · 2026 · Diabetic Medicine
- Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled TrialTom Wilkinson, Natalie Nanayakkara, David Burren, Alicia Jenkins, Jonathan A. Williman, Celeste Keesing, Erin Boyle, Yasser Elghattis, Alison Bennett, Tim C. Gunn et al. · 2026 · Diabetes Technology & Therapeutics
- A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemiaFaye Baxter, Nicola Baillie, Anna R. Dover, Roland H. Stimson, Fraser W. Gibb, Shareen Forbes · 2024 · PLoS ONE
- Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variabilityLouis Monnier, C Colette, Éric Renard, Pierre‐Yves Benhamou, Safa Aouinti, Nicolas Molinari, David Owens · 2024 · Diabetes & Metabolism
- Time in tight glucose range in adolescents and young adults with diabetes during Ramadan intermittent fasting: Data from real-world users on different treatment strategiesNancy Samir Elbarbary, Eman Abdel Rahman Ismail · 2025 · Diabetes Research and Clinical Practice
- 1921–2021: From insulin discovery to islet transplantation in type 1 diabetesMikaël Chetboun, Arnaud Jannin, Julie A. Kerr-Conte, François N. Pattou, Marie‐Christine Vantyghem · 2021 · Annales d Endocrinologie
- The Evolution of Insulin Administration in Type 1 DiabetesCatherina T. Pinnaro, Michael Tansey · 2021 · Journal of Diabetes Mellitus
- Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationaleSimona de Portu, Linda Vorrink, Roseline Ré, John Shin, Javier Castañeda, Aklilu Habteab, Ohad Cohen · 2022 · BMJ Open
- Effect of an Automated Advice Algorithm (CloudConnect) on Adolescent-Parent Diabetes-Specific Communication and Glycemic Management: A Randomized TrialMark Daniel DeBoer, Rupa S. Valdez, John P. Corbett, Katie Krauthause, CHRISTIAN A. WAKEMAN, Alexander S. Luke, Mary Clancy Oliveri, Daniel R. Cherñavvsky, Stephen D. Patek · 2023 · Diabetes Therapy
- Diabetes technology including automated insulin delivery systems to manage hyperglycemia in a failing pancreatic graft: Case series of people with type 1 diabetes and a pancreas kidney or pancreas‐only transplantDimitra Stathi, Thomas Johnston, Rebecca Hyslop, Anna Brackenridge, Janaka J. Karalliedde · 2023 · Journal of Diabetes Investigation
- An mHealth Text Messaging Program Providing Symptom Detection Training and Psychoeducation to Improve Hypoglycemia Self-Management: Intervention Development StudyYu Kuei Lin, James E. Aikens, Nicole de Zoysa, Diana Hall, Martha M. Funnell, Robin B Nwankwo, K Kloss, Melissa J. DeJonckheere, Rodica Pop‐Busui, Gretchen Piatt et al. · 2023 · JMIR Formative Research
- Automated insulin delivery systems in elderly patients with brittle type 2 diabetesÖzge Telci Çaklılı, Ferhat Cetin, M. Kuday Özkan, Elif Şahiner, Ramazan Çakmak, Ela Keskin, Hülya Hacışahinoğulları, Enver Sukru Goncuoglu, Mehmet Temel Yilmaz · 2024 · Diabetes Research and Clinical Practice
- A Comparison of Glucose and Additional Signals for Three Different Exercise Types in Adolescents with Type 1 Diabetes Using a Hybrid Closed-Loop SystemRowen Seckold, Carmel E. Smart, David Norman O'Neal, Michael Charles Riddell, Jordan Rafferty, Dale Morrison, Varuni R. Obeyesekere, JL Gooley, Barbora Paldus, Sarah Ruth Valkenborghs et al. · 2025 · Diabetes Technology & Therapeutics
- Efficacy and safety of a tubeless open‐source hybrid automated insulin delivery use at home among adults with type 1 diabetes mellitus: Results from a 26‐week, free‐living, randomized crossover trialMengyun Lei, Ping Ling, Beisi Lin, Jing Lv, Zhigu Liu, Yongwen Zhou, Hongrong Deng, Daizhi Yang, Chaofan Wang, Xubin Yang et al. · 2025 · Diabetes Obesity and Metabolism
- The Tandem Control-IQ advanced hybrid system improves glycemic control in children under 18 years of age with type 1 diabetes and night rest in caregiversAndrés Mingorance Delgado, Fernando Lucas · 2023 · Endocrinología Diabetes y Nutrición (English ed )
- Women’s and Partners’ Experiences With a Closed-loop Insulin Delivery System to Manage Type 1 Diabetes in the Postpartum PeriodMaira Quintanilha, Jennifer M. Yamamoto, Breanne Aylward, Denice S. Feig, Patricia Lemieux, Helen R. Murphy, Ronald Jeremy Sigal, Josephine Ho, Heidi Virtanen, Susan G. Crawford et al. · 2024 · Canadian Journal of Diabetes
- Hybrid closed loop insulin therapy versus standard therapy in pregnant women with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trialsSohaira Tahir, Shafia Naeem, Izzah Nayyab, Aafia Batool, Sameer Emeish, Ilma Hasan, Arjun Dhir, Jawad Shahid, Muhammad Abdullah Sheraz, Jaskaran Singh et al. · 2025 · European Journal of Obstetrics & Gynecology and Reproductive Biology
- Significant Improvement in Glycemic Control after Initiation of AHCL in Children with Type 1 Diabetes: A Single Center Prospective StudyGül Yeşiltepe Mutlu, Elif Eviz, Ecem Can, Tuğba Gökçe, Serra Muradoğlu, Şükrü Hatun · 2023 · Clinical Diabetology
- Diabetestechnologie (Update 2023)Ingrid Schütz-Fuhrmann, Birgit M. Rami-Merhar, Elke Elisabeth Fröhlich-Reiterer, Sabine E. Hofer, Martin Tauschmann, Julia Katharina Mader, Michael Resl, Alexandra Kautzky‐Willer, Yvonne Winhofer-Stöckl, Markus Laimer et al. · 2023 · Wiener klinische Wochenschrift
- Results From a Virtual Clinic for the Follow-up of Patients Using the Advanced Hybrid Closed-Loop SystemAna María Gómez Medina, Diana Cristina Henao, Julio David Silva León, Javier Alberto Gómez González, Óscar Múñoz, Lucia Conde Brahim, Guillermo Andrés Mecón Prada, Martín Rondón · 2023 · Journal of Diabetes Science and Technology
- Advanced technology for type 1 diabetes care in a deaf-mute patientBasilio Pintaudi, Alessandro Nani, Ilaria Gironi, Federico Bertuzzi · 2022 · BMJ Case Reports
- The Influence of Digital Affinity on the Continuous Glucose Monitoring System Choice by People With Type 1 DiabetesCarolin Kinzel, Burkhard J. Manfras · 2022 · Journal of Diabetes Science and Technology
- Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical DataLisa A. de Jong, Xinyu Li, Sajad Emamipour, Sjoukje van der Werf, Maarten Jacobus Postma, Peter Ruben van Dijk, Talitha Feenstra · 2024 · PharmacoEconomics
- Empfehlungen zur Diabetes-Behandlung mit automatischen Insulin-DosierungssystemenThekla von dem Berge, Sarah Biester, Torben Biester, Anne-Kathrin Buchmann, Nicolin Datz, Ute Grosser, Kerstin Kapitzke, Britta Klusmeier, K Remus, Felix Reschke et al. · 2021 · Diabetologie und Stoffwechsel
- Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemicAbhishek Sathyanarayanan, Thomas Simon James Crabtree, Pratik Choudhary, Daisy Elliott, Mark L. Evans, Alistair N. Lumb, Emma G. Wilmot · 2022 · Diabetes Research and Clinical Practice
- Improving glycemic control by transitioning from the MiniMedTM 640G to 770G in Japanese adults with type 1 diabetes mellitus: a prospective, single-center, observational studySatoshi Kubota, Ai Sato, Manami Hosokawa, Yosuke Okubo, Shohei Takayama, Atsuko Kaneko, Yasuho Shimada, Yuki Asano, Yoshihiko Sato, Masanori Yamazaki et al. · 2024 · Endocrine Journal
- Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.Fleur Levrat‐Guillen, Tara Ghazi · 2022 · Diabetes Therapy
- Real‐world glycaemic outcomes in children and young people on advanced hybrid closed‐loop therapy: A population‐based study in Western AustraliaFrances Ellen Gehrmann, Grant J. Smith, Kathleen Irwine, Katrina L. Ellis, Elizabeth Ann Davis, Timothy William Jones, Craig E. Taplin, Mary Binsu Abraham · 2024 · Journal of Paediatrics and Child Health
- Effect of Automated Insulin Delivery System Therapy at Diagnosis on Metabolic Control in Children and Adolescents with Type 1 DiabetesUğur Cem Yılmaz, Günay Demir, Deniz Özalp Kızılay, Samim Özen, Damla Gökşen · 2025 · Diabetes Therapy
- Experiences with Simplera sync™ all‐in‐one sensors and extended wear infusion sets in adolescents and young adults using the MiniMed ™ 780G : A qualitative studyVenus R. Michaels, Hamish R. Crocket, Alisa Boucsein, Yongwen Zhou, Ryan G. Paul, Esko J. Wiltshire, Craig Jefferies, Martin I. de Bock, Benjamin John Wheeler · 2025 · Diabetic Medicine
- Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT TrialMarcus C Ward, Alisa Boucsein, Yongwen Zhou, Venus R. Michaels, Jillian Joy Haszard, Craig Jefferies, Esko J. Wiltshire, Ryan G. Paul, Caleb A Lopez-Sanchez, Martin I. de Bock et al. · 2026 · Diabetes Technology & Therapeutics
- Learning control-ready forecasters for Blood Glucose ManagementHarry Rubin‐Falcone, Joyce M. Lee, Jenna Wiens · 2024 · Computers in Biology and Medicine
- Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetesLía Nattero‐Chávez, Esther de la Calle de la Villa, Edurne Lecumberri Pascual, Ane Bayona Cebada, Teresa Ruiz Gracia, Alejandra Quintero Tobar, Mar Lorenzo Moñino, Cristina Sánchez Rodríguez, Ana Izquierdo, Héctor Francisco Escobar-Morreale et al. · 2024 · Therapeutic Advances in Endocrinology and Metabolism
- Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemiaPeter Novodvorský, Alan Bernjak, Ellen Downs, Amelia Smith, Muhammad Fahad Arshad, Andrei I. Oprescu, Richard Jacques, Justin Lee, Simon R. Heller, Ahmed Iqbal · 2025 · Diabetic Medicine
- The Effect of Do-It-Yourself Real-Time Continuous Glucose Monitoring on Glycemic Variables and Participant-Reported Outcomes in Adults With Type 1 Diabetes: A Randomized Crossover TrialShekhar Sehgal, Mona M. Elbalshy, Jonathan A. Williman, Barbara C. Galland, Hamish R. Crocket, Rosemary M. Hall, Ryan G. Paul, Robert Leikis, Martin I. de Bock, Benjamin John Wheeler · 2023 · Journal of Diabetes Science and Technology
- Clinical Translation and Implementation of a Bioartificial Pancreas Therapy: A Qualitative Study Exploring the Perspectives of People With Type 1 DiabetesDide de Jongh, Silke Lapré, Behiye Özcan, Robert Zietse, Eline Maria Bunnik, Emma K. Massey · 2024 · Transplantation Direct
- First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 DiabetesTom Wilkinson, Solita Donnelly, Claire S. Lever, Jonathan A. Williman, Renee A. Meier, Alisa Boucsein, Shirley Jones, Dave Ballagh, Reon van Rensburg, Rachael Sampson et al. · 2025 · Journal of Diabetes Science and Technology